EVAX (Evaxion AS) Total Liabilities: $9.85 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

EVAX Evaxion AS EVAX
48 GF Score
Price $3.35
GF Value $3.34
Valuation Fairly Valued
! 2 Warning Signs
View Full Analysis

What is Evaxion AS Total Liabilities?

Evaxion AS EVAX -0.89% 48 Total Liabilities is $9.85 Mil as of Jun. 2026. GuruFocus rates EVAX with a GF Score™ of 48/100 and a GF Value™ of $3.34 (Fairly Valued). The stock has 2 warning signs investors should review.

Evaxion AS's Total Liabilities for the quarter that ended in Jun. 2026 was $9.85 Mil.

Evaxion AS's quarterly Total Liabilities declined from Dec. 2025 ($11.37 Mil) to Mar. 2026 ($10.44 Mil) and declined from Mar. 2026 ($10.44 Mil) to Jun. 2026 ($9.85 Mil).

Evaxion AS's annual Total Liabilities declined from Dec. 2023 ($17.62 Mil) to Dec. 2024 ($14.14 Mil) and declined from Dec. 2024 ($14.14 Mil) to Dec. 2025 ($11.37 Mil).

Evaxion AS Total Liabilities Historical Data

* Premium members only.

The historical data trend for Evaxion AS's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Evaxion AS Total Liabilities Chart

Evaxion AS Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Liabilities
Get a 7-Day Free Trial Premium Member Only 7.73 13.72 17.62 14.14 11.37

Evaxion AS Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 16.22 13.14 11.37 10.44 9.85
EVAX
48GF Score
Evaxion AS EVAX
Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Evaxion AS Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Evaxion AS's Total Liabilities for the fiscal year that ended in Dec. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=4.257+(6.954+0.158
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=11.37

Total Liabilities=Total Assets (A: Dec. 2025 )-Total Equity (A: Dec. 2025 )
=28.408-17.039
=11.37

Evaxion AS's Total Liabilities for the quarter that ended in Jun. 2026 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=3.133+(6.563+0.153
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=9.85

Total Liabilities=Total Assets (Q: Jun. 2026 )-Total Equity (Q: Jun. 2026 )
=19.38-9.531
=9.85

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of $9.85 Mil mean?
Evaxion AS (EVAX) has a Total Liabilities of $9.85 Mil as of Jun. 2026. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Evaxion AS and its competitors.
Is Evaxion AS's Total Liabilities too high?
Evaxion AS's current Total Liabilities is $9.85 Mil. Overall, Evaxion AS has a GF Score™ of 48/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Evaxion AS's Total Liabilities compare to CRVO and ALGS?
Evaxion AS's Total Liabilities of $9.85 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Biotechnology company?
A good Total Liabilities depends on the Biotechnology industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Evaxion AS and its competitors. Evaxion AS's current Total Liabilities is $9.85 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Evaxion AS stock overvalued right now?
Based on GuruFocus' analysis, Evaxion AS (EVAX) is currently considered Fairly Valued. The stock's GF Value™ is $3.34, compared to a current price of $3.35 — trading 0.3% above its estimated fair value. The current Total Liabilities is $9.85 Mil. Evaxion AS's overall GF Score™ is 48/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Evaxion AS (EVAX), the current Total Liabilities is $9.85 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Evaxion AS (EVAX) Overvalued in 2026?

Based on GuruFocus' analysis, Evaxion AS stock appears to be overvalued. The current stock price of $3.35 is trading 0.3% above its estimated GF Value™ of $3.34. GuruFocus considers Evaxion AS to be Fairly Valued.

Key valuation signals for EVAX:

  • Total Liabilities: $9.85 Mil
  • GF Value™: $3.34 vs. price of $3.35 (0.3% above fair value)
  • GF Score™: 48/100 with 2 warning signs

No single metric tells the full story. See the EVAX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Evaxion AS Business Description

Address Dr. Neergaards Vej 5f, Horsholm, DNK, 2970
Evaxion AS is a clinical-stage TechBio company developing novel vaccines with its proprietary, clinically validated and scalable AI platform, AI-Immunology. The platform harnesses the power of artificial intelligence to decode the human immune system and develop novel vaccine candidates for cancer and infectious diseases for patients in the market. Evaxion has developed a clinical-stage oncology pipeline of novel personalised vaccines and a preclinical infectious disease pipeline in bacterial and viral diseases with high unmet medical needs. The group is committed to transforming patients' lives by providing inventive and targeted treatment options.
48GF Score

Get the complete analysis for EVAX

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$3.35
Price
$3.34
GF Value